Omeprazol Teva (Omeprazole)

Omeprazole, the active ingredient in Omeprazol Teva, is a proton pump inhibitor presented as an oral tablet for oral use. It reduces gastric acid production and is used to treat conditions such as gastro‑esophageal reflux disease, peptic ulcer disease and related disorders. GNH USA supplies Omeprazol Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omeprazol Teva, a proton pump inhibitor, acts on acid‑related gastrointestinal disorders. - Gastro‑esophageal reflux disease (GERD): reduces reflux symptoms and promotes healing of esophageal irritation. - Peptic ulcer disease: facilitates ulcer healing and prevents recurrence. - NSAID‑induced ulcer prophylaxis: protects gastric mucosa in patients receiving NSAIDs. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion.

Common Side Effects: - Headache: mild, transient discomfort. - Diarrhea: loose, watery stools. - Abdominal pain: discomfort in the stomach area. - Nausea: feeling of sickness.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, or breathing difficulty. - Low magnesium levels: muscle cramps or irregular heartbeat. - Clostridium difficile‑associated colitis: severe diarrhea with abdominal pain.

Precautions for Omeprazol Teva include: - Assess renal function: dose may need adjustment in severe renal impairment. - Monitor magnesium: prolonged therapy can cause hypomagnesemia. - Avoid concomitant use with strong CYP2C19 inhibitors unless necessary. - Use with caution in patients with liver disease. - Pregnancy and lactation: discuss potential risks with a healthcare provider. - Store at ambient temperature: keep in the original container, protect from moisture and light.

Omeprazol Teva may interact with several medicines. Major Interactions (Avoid): - Ketoconazole: reduced absorption and effectiveness. - Atazanavir: decreased antiviral activity. - Clopidogrel: reduced conversion to its active metabolite. Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR, monitor coagulation. - Digoxin: may raise serum digoxin concentrations.